October 4, 2016 William K. McVicar, Ph.D.Transition Agreement • November 9th, 2016 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations • Massachusetts
This letter confirms that you will be transitioning from your role as Executive Vice President, Chief Scientific Officer at Inotek Pharmaceuticals Corporation (“Inotek” or the “Company”). On behalf of the Company and its Board of Directors (the “Board”), please accept our sincere appreciation for your years of service and contributions to the Company. With that in mind, this letter proposes an agreement setting forth the terms of your transition (the “Agreement”).
